Codes / ICD10CM / M1A.21

M1A.21 Drug-induced chronic gout, shoulder

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Drug-Induced Chronic Gout, Shoulder

Summary

Drug-induced chronic gout, shoulder is a form of arthritis affecting the shoulder joint, resulting from prolonged elevated uric acid levels due to medication use. It leads to recurrent joint inflammation and potential tissue damage, characterized by persistent symptoms and may involve the formation of tophi (urate crystal deposits) in advanced stages.

Causes

This condition arises from medications that interfere with uric acid metabolism or excretion, causing accumulation in the blood. Over time, urate crystals deposit in the shoulder joint and surrounding tissues, triggering inflammation. Common culprits include diuretics, low-dose aspirin, and certain chemotherapy agents.

Risk Factors

  • Use of medications that increase uric acid levels (e.g., diuretics, low-dose aspirin)
  • Prolonged exposure to urate-raising drugs
  • Pre-existing hyperuricemia or gout history
  • Renal impairment affecting drug clearance

Symptoms

  • Recurrent episodes of intense shoulder pain, often with swelling and redness
  • Persistent warmth and tenderness in the affected shoulder
  • Formation of tophi (hard, painless lumps) around the shoulder joint
  • Stiffness and limited range of motion in the shoulder
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves clinical evaluation, laboratory tests, and imaging. Blood tests measure uric acid levels, while joint fluid analysis detects urate crystals. Imaging may assess joint damage or tophi presence. The shoulder-specific location is confirmed through physical examination and targeted imaging.

Treatment Options

Treatment focuses on reducing uric acid levels and managing symptoms. Medications may include urate-lowering agents (e.g., allopurinol) and anti-inflammatory drugs. Injections or physical therapy may address shoulder-specific symptoms. Lifestyle modifications, such as dietary changes, may also be recommended.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, but chronic damage may persist. Regular follow-up monitors uric acid levels and joint health. Untreated cases may lead to progressive joint damage or tophi formation.

Complications

  • Chronic shoulder pain and functional impairment
  • Tophi formation in or around the shoulder joint
  • Joint deformity or limited mobility
  • Increased risk of acute gout flares

Lifestyle & Prevention

  • Avoid medications known to raise uric acid levels when possible
  • Maintain a balanced diet low in purines (e.g., limit red meat, alcohol)
  • Stay hydrated to support uric acid excretion
  • Follow prescribed treatment plans consistently

When to Seek Professional Help

Seek care if shoulder pain is severe, persistent, or worsening, or if symptoms interfere with daily activities. Prompt evaluation is needed for signs of infection or acute flare-ups.

Tips for Medical Coders

Document the shoulder-specific location and confirm drug-induced etiology. Ensure clinical notes support the diagnosis, including medication history and joint involvement. Code M1A.21 is specific to the shoulder; verify no other site is indicated.

Book a walkthrough

M1A.21 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.